Profil
Andrew M.
Sadosky worked as a Director at Primus Therapeutics, Inc. from 2010 to 2011.
He holds an MBA from the University of Pennsylvania and an undergraduate degree from Rutgers State University of New Jersey.
Anciens postes connus de Andrew M. Sadosky
| Sociétés | Poste | Fin |
|---|---|---|
Primus Therapeutics, Inc.
 Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Directeur/Membre du Conseil | 01/01/2011 |
Formation de Andrew M. Sadosky
| University of Pennsylvania | Masters Business Admin |
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Primus Therapeutics, Inc.
Primus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Primus Therapeutics, Inc. is a development stage company. It intends to license, develop, market and sell consumer self-care products for preventing and ameliorating the symptoms of common ailments such as cough, cold, influenza, joint pain, gingivitis, products promoting cardiovascular health and analgesics for muscle pain/inflammation. It intends to sell its products under the trademarks PreVenza and Duract. The company was founded by Dennis M. O'Donnell on August 17, 2010 and is headquartered in Skillman, NJ. | Health Technology |
